Trial Profile
Vedolizumab trough levels following randomised withdrawal of immunomodulator in ulcerative colitis patients in remission
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary) ; Azathioprine; Mercaptopurine
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Acronyms VIEWS
- 15 May 2018 New trial record